ArticleCase reports in rheumatology2014

High-dose subcutaneous immunoglobulins for the treatment of severe treatment-resistant polymyositis.

Cherin Patrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.